Adalimumab/infliximabDevelopment of drug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1893卷 / 1期

关键词：

D O I：

10.1007/s40278-022-09801-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：18 / 18

相关论文

共 50 条

[21] InfliximabDevelopment of anti-infliximab antibodies, rash and fever: case report
Reactions Weekly, 2019, 1775 (1) : 259 - 259
[22] TemozolomideThrombocytopenia and drug resistance: case report
Reactions Weekly, 2021, 1845 (1) : 356 - 356
[23] IsoniazidAcquired drug resistance: case report
Reactions Weekly, 2019, 1776 (1) : 251 - 251
[24] ClopidogrelDevelopment of drug resistance: case report
Reactions Weekly, 2021, 1840 (1) : 129 - 129
[25] ErlotinibDevelopment of drug resistance: case report
Reactions Weekly, 2021, 1862 (1) : 206 - 206
[26] RifampicinDevelopment of drug resistance: case report
Reactions Weekly, 2018, 1703 (1) : 234 - 234
[27] ValganciclovirEmergence of drug resistance: case report
Reactions Weekly, 2022, 1904 (1) : 448 - 448
[28] IcotinibAcquired drug resistance: case report
Reactions Weekly, 2021, 1877 (1) : 188 - 188
[29] GefitinibAcquired drug resistance: case report
Reactions Weekly, 2021, 1880 (1) : 189 - 189
[30] VemurafenibAcquired drug resistance: case report
Reactions Weekly, 2021, 1836 (1) : 763 - 763

← 1 2 3 4 5 →